SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-09-101084
Filing Date
2009-05-06
Accepted
2009-05-06 11:35:47
Documents
7
Period of Report
2009-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 432284
2 THIRD AMENDMENT TO SUBLEASE dex101.htm EX-10.1 52043
3 CERTIFICATION OF PEO PURSUANT TO SECTION 302 dex311.htm EX-31.1 6643
4 CERTIFICATION OF PFO PURSUANT TO SECTION 302 dex312.htm EX-31.2 6658
5 CERTIFICATION OF PEO PURSUANT TO SECTION 906 dex321.htm EX-32.1 2892
6 CERTIFICATION OF PFO PURSUANT TO SECTION 906 dex322.htm EX-32.2 2908
7 GRAPHIC g70842ex101_p6.jpg GRAPHIC 160784
  Complete submission text file 0001193125-09-101084.txt   726717
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31141 | Film No.: 09800238
SIC: 2834 Pharmaceutical Preparations